Last 7 days
41.8%
Last 30 days
31.5%
Last 90 days
-5.2%
Trailing 12 Months
25.2%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 51.7M | 54.6M | 57.7M | 0 |
2022 | 49.4M | 49.9M | 49.7M | 51.5M |
2021 | 22.1M | 32.3M | 38.6M | 43.5M |
2020 | 6.3M | 7.3M | 12.3M | 17.4M |
2019 | 2.1M | 2.1M | 2.5M | 4.2M |
2018 | 1.8M | 2.0M | 2.0M | 2.0M |
2017 | 1.9M | 1.9M | 1.9M | 1.9M |
2016 | 1.8M | 1.8M | 1.8M | 1.9M |
2015 | 1.2M | 1.5M | 1.8M | 1.8M |
2014 | 0 | 0 | 0 | 772.0K |
2013 | 0 | 0 | 0 | 0 |
2012 | 0 | 0 | 0 | 10.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Aug 30, 2023 | mattessich antony c. | bought | 24,765 | 3.81 | 6,500 | president and ceo |
Jul 10, 2023 | graves adrienne l | acquired | - | - | 24,000 | - |
Jul 07, 2023 | ozden rabia gurses | sold | -4,101 | 4.93 | -832 | chief medical officer |
Jun 14, 2023 | hong seung suh | acquired | - | - | 12,000 | - |
Jun 14, 2023 | williams leslie j. | acquired | - | - | 12,000 | - |
Jun 14, 2023 | heier jeffrey s. | acquired | - | - | 12,000 | - |
Jun 14, 2023 | lindstrom richard l md | acquired | - | - | 12,000 | - |
Jun 14, 2023 | warden charles m | acquired | - | - | 12,000 | - |
Jun 14, 2023 | raines merilee | acquired | - | - | 12,000 | - |
Feb 06, 2023 | mattessich antony c. | sold | -83,396 | 4.24 | -19,669 | president and ceo |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Nov 27, 2023 | TRUST CO OF VERMONT | added | 25.00 | -4,940 | 15,700 | -% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | added | 19.99 | -41,553 | 112,431 | -% |
Nov 22, 2023 | Graham Capital Management, L.P. | new | - | 299,439 | 299,439 | 0.01% |
Nov 21, 2023 | Walleye Trading LLC | sold off | -100 | -232,793 | - | -% |
Nov 21, 2023 | Walleye Capital LLC | sold off | -100 | -225,311 | - | -% |
Nov 16, 2023 | Financial Gravity Asset Management, Inc. | sold off | -100 | -11.00 | - | -% |
Nov 15, 2023 | Tudor Investment Corp Et Al | reduced | -13.28 | -489,466 | 546,884 | -% |
Nov 15, 2023 | JANE STREET GROUP, LLC | reduced | -76.54 | -1,137,960 | 189,543 | -% |
Nov 15, 2023 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | unchanged | - | -64,109 | 99,654 | -% |
Nov 15, 2023 | GSA CAPITAL PARTNERS LLP | added | 96.36 | 119,000 | 733,000 | 0.06% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | opaleye management inc. | 7.89% | 6,075,000 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 5.16% | 3,976,853 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 6.4% | 4,952,737 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 6.7% | 5,122,835 | SC 13G/A | |
Feb 01, 2022 | opaleye management inc. | 7.80% | 5,974,800 | SC 13G/A | |
Feb 12, 2021 | opaleye management inc. | 8.65% | 9 | SC 13G/A | |
Feb 02, 2021 | blackrock inc. | 7.3% | 5,512,264 | SC 13G | |
Jun 09, 2020 | blackrock inc. | 4.8% | 3,006,167 | SC 13G/A | |
May 21, 2020 | summer road llc | 17.0% | 11,387,656 | SC 13D/A | |
Mar 25, 2020 | summer road llc | 18.9% | 11,024,020 | SC 13D/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 16, 2023 | EFFECT | EFFECT | |
Nov 07, 2023 | S-3 | S-3 | |
Nov 07, 2023 | 8-K | Current Report | |
Nov 07, 2023 | 10-Q | Quarterly Report | |
Oct 04, 2023 | 8-K | Current Report | |
Oct 03, 2023 | 8-K | Current Report | |
Sep 13, 2023 | 8-K | Current Report | |
Sep 05, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HILS | 31.4B | - | 4.92% | 426363.59% | -3.6K | 218.4K | - | -102.45% |
MRNA | 30.7B | 10.7B | 11.84% | -53.56% | -8.86 | 2.88 | -53.67% | -129.46% |
ALNY | 22.0B | 1.7B | 4.71% | -20.32% | -43.06 | 12.74 | 79.37% | 56.87% |
BMRN | 17.7B | 2.3B | 23.54% | -7.88% | 120.62 | 7.68 | 15.05% | 75.21% |
INCY | 12.4B | 3.6B | 1.56% | -32.86% | 29.22 | 3.44 | 8.35% | -51.49% |
MID-CAP | ||||||||
APLS | 7.5B | 272.9M | 38.55% | 34.32% | -12.3 | 27.32 | 141.38% | 4.43% |
BBIO | 5.6B | - | 16.25% | 246.63% | -9.66 | 48.33 | 54.84% | -12.96% |
ACAD | 3.5B | 631.9M | -10.80% | 43.56% | -23.56 | 5.55 | 23.54% | 31.53% |
AXSM | 3.3B | 223.4M | 11.07% | -7.88% | -16.26 | 14.69 | - | -26.24% |
ARWR | 2.6B | 240.7M | -11.66% | -25.68% | -12.44 | 10.6 | -1.03% | -16.59% |
SMALL-CAP | ||||||||
CPRX | 1.5B | 348.4M | 7.85% | -14.88% | 24.07 | 4.29 | 81.69% | -7.29% |
NVAX | 662.5M | 1.0B | -19.01% | -66.75% | -1.21 | 0.63 | -43.15% | 58.48% |
INO | 100.5M | 6.4M | -2.56% | -78.77% | -0.61 | 15.6 | -44.11% | 50.48% |
IBIO | 42.3M | - | 410.00% | -4.38% | -0.65 | - | - | -29.23% |
CRBP | 26.3M | - | 17.86% | 4717.52% | -0.55 | - | - | -13.74% |
Income Statement (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | -0.7% | 15,081 | 15,186 | 13,374 | 14,076 | 11,965 | 12,266 | 13,187 | 12,309 | 12,153 | 11,718 | 7,342 | 7,349 | 5,876 | 1,569 | 2,609 | 2,256 | 829 | 650 | 492 | 504 | 498 |
Costs and Expenses | -4.1% | 34,295 | 35,756 | 35,923 | 33,437 | 33,509 | 32,182 | 31,020 | 30,358 | 31,682 | 31,949 | 27,570 | 21,692 | 19,882 | 19,453 | 19,223 | 23,657 | 23,973 | 22,249 | 20,150 | 17,787 | 15,314 |
S&GA Expenses | -16.5% | 9,315 | 11,153 | 10,835 | 10,533 | 10,186 | 10,140 | 9,063 | 9,137 | 9,576 | 8,391 | 8,086 | 6,811 | 6,520 | 6,153 | 7,130 | 7,142 | 6,777 | 7,225 | 3,347 | 2,291 | 1,067 |
R&D Expenses | -0.5% | 15,019 | 15,094 | 14,747 | 13,543 | 13,719 | 13,100 | 13,100 | 12,578 | 12,719 | 13,859 | 10,927 | 7,624 | 6,951 | 8,021 | 6,098 | 10,125 | 10,235 | 9,414 | 11,317 | 10,258 | 9,685 |
Interest Expenses | 72.1% | 3,426 | 1,991 | 1,768 | 1,847 | 1,797 | 1,696 | 1,683 | 1,680 | 1,658 | 1,655 | 1,679 | 1,726 | 1,715 | 1,694 | 1,633 | 1,805 | 1,651 | 1,627 | 1,018 | 374 | 424 |
Net Income | 97.5% | -516 | -20,682 | -30,318 | -15,542 | -24,188 | -18,766 | -12,542 | -3,850 | 2,657 | -8,481 | 3,121 | -85,612 | -11,944 | -36,568 | -21,512 | -26,017 | -18,778 | -24,453 | -17,124 | -17,399 | -15,010 |
Net Income Margin | - | - | - | -1.72* | -1.38* | -1.19* | -0.65* | -0.45* | -0.15* | -2.29* | -3.19* | -5.92* | -8.94* | -7.80* | -14.16* | -14.31* | -20.43* | - | - | - | - | - |
Free Cashflow | - | - | - | -23,352 | -19,108 | -13,963 | -11,371 | -18,876 | -15,784 | -13,258 | -20,185 | -17,517 | -6,499 | -13,872 | -14,921 | -19,103 | -20,068 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 32.5% | 162 | 123 | 129 | 149 | 159 | 173 | 188 | 205 | 218 | 231 | 243 | 262 | 98.00 | 107 | 73.00 | 79.00 | 89.00 | 90.00 | 101 | 73.00 | 70.00 |
Current Assets | 40.3% | 141 | 101 | 107 | 130 | 146 | 160 | 175 | 191 | 204 | 217 | 228 | 246 | 82.00 | 90.00 | 55.00 | 60.00 | 70.00 | 65.00 | 79.00 | 56.00 | 58.00 |
Cash Equivalents | 68.6% | 112 | 67.00 | 79.00 | 102 | 121 | 135 | 145 | 166 | 179 | 192 | 209 | 228 | 71.00 | 84.00 | 48.00 | 56.00 | 65.00 | 62.00 | 76.00 | 61.00 | 57.00 |
Inventory | 2.4% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
Net PPE | -2.6% | 12.00 | 13.00 | 12.00 | 10.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 8.00 | 8.00 | 8.00 | 9.00 | 9.00 | 10.00 | 10.00 | 11.00 | 11.00 | 10.00 | 10.00 |
Liabilities | 29.3% | 155 | 119 | 119 | 114 | 112 | 107 | 108 | 117 | 130 | 150 | 160 | 186 | 102 | 102 | 84.00 | 82.00 | 77.00 | 81.00 | 76.00 | 37.00 | 25.00 |
Current Liabilities | 8.4% | 35.00 | 32.00 | 30.00 | 31.00 | 29.00 | 26.00 | 24.00 | 26.00 | 25.00 | 22.00 | 27.00 | 27.00 | 23.00 | 14.00 | 11.00 | 12.00 | 11.00 | 10.00 | 9.00 | 9.00 | 13.00 |
Shareholder's Equity | 154.4% | 8.00 | 3.00 | 10.00 | 35.00 | 46.00 | 66.00 | 80.00 | 88.00 | 87.00 | 80.00 | 83.00 | 76.00 | - | 5.00 | - | - | 11.00 | 8.00 | 26.00 | 36.00 | 46.00 |
Retained Earnings | -0.1% | -668 | -667 | -647 | -616 | -601 | -577 | -558 | -545 | -541 | -544 | -536 | -539 | -453 | -441 | -405 | -383 | -357 | -338 | -314 | -297 | -279 |
Additional Paid-In Capital | 0.8% | 676 | 671 | 657 | 652 | 648 | 643 | 638 | 634 | 629 | 625 | 620 | 615 | 450 | 447 | 394 | 380 | 369 | 347 | 340 | 333 | 325 |
Shares Outstanding | 0.2% | 79.00 | 79.00 | 78.00 | 77.00 | 77.00 | 77.00 | 77.00 | 77.00 | 77.00 | 76.00 | 76.00 | 76.00 | 63.00 | 57.00 | 52.00 | 50.00 | 47.00 | 43.00 | 42.00 | 42.00 | 39.00 |
Cashflow (Quarterly) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 61.5% | -7,732 | -20,075 | -19,973 | -16,958 | -13,169 | -10,876 | -18,600 | -15,153 | -12,982 | -20,056 | -17,359 | -6,246 | -13,658 | -14,796 | -18,854 | -19,467 | -19,544 | -19,181 | -19,386 | -13,648 | -10,873 |
Share Based Compensation | 2.2% | 4,512 | 4,413 | 4,572 | 4,234 | 4,240 | 4,281 | 4,209 | 3,841 | 3,758 | 4,292 | 3,086 | 2,104 | 1,936 | 1,826 | 1,665 | 1,953 | 3,169 | 1,695 | 1,942 | 1,949 | 1,873 |
Cashflow From Investing | 87.0% | -259 | -1,990 | -3,379 | -2,150 | -794 | -495 | -276 | -631 | -276 | -129 | -158 | -253 | -214 | -125 | -249 | -601 | -419 | -493 | -725 | -479 | -473 |
Cashflow From Financing | 438.5% | 51,935 | 9,645 | 78.00 | 458 | 374 | 493 | 129 | 667 | 679 | 2,667 | -1,162 | 163,913 | 220 | 51,063 | 12,818 | 9,091 | 18,612 | 5,338 | 42,300 | 16,328 | 11,373 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenue: | ||||
Total revenue, net | $ 15,081 | $ 11,965 | $ 43,642 | $ 37,419 |
Costs and operating expenses: | ||||
Cost, Product and Service [Extensible List] | Product revenue, net | Product revenue, net | Product revenue, net | Product revenue, net |
Cost of product revenue | $ 1,377 | $ 1,073 | $ 3,895 | $ 3,528 |
Research and development | 15,019 | 13,719 | 44,860 | 39,919 |
Selling and marketing | 9,315 | 10,186 | 31,304 | 29,390 |
General and administrative | 8,584 | 8,531 | 25,915 | 23,875 |
Total costs and operating expenses | 34,295 | 33,509 | 105,974 | 96,712 |
Loss from operations | (19,214) | (21,544) | (62,332) | (59,293) |
Other income (expense): | ||||
Interest income | 1,212 | 285 | 2,524 | 375 |
Interest expense | (3,426) | (1,797) | (7,187) | (5,175) |
Change in fair value of derivative liabilities | 6,722 | (1,133) | 1,290 | 8,598 |
Gains and losses on extinguishment of debt, net | 14,190 | 14,190 | ||
Other income (expense), net | 1 | (1) | (1) | |
Total other income (expense), net | 18,698 | (2,644) | 10,816 | 3,797 |
Net loss | $ (516) | $ (24,188) | $ (51,516) | $ (55,496) |
Net loss per share, basic | $ (0.01) | $ (0.31) | $ (0.66) | $ (0.72) |
Weighted average common shares outstanding, basic | 79,373,272 | 76,975,839 | 78,276,341 | 76,829,434 |
Net loss per share, diluted | $ (0.25) | $ (0.31) | $ (0.77) | $ (0.73) |
Weighted average common shares outstanding, diluted | 85,142,504 | 76,975,839 | 84,045,573 | 82,598,666 |
Product revenue, net | ||||
Revenue: | ||||
Total revenue, net | $ 14,950 | $ 11,913 | $ 43,193 | $ 36,555 |
Collaboration revenue | ||||
Revenue: | ||||
Total revenue, net | $ 131 | $ 52 | $ 449 | $ 864 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 110,550 | $ 102,300 |
Accounts receivable, net | 23,589 | 21,325 |
Inventory | 2,257 | 1,974 |
Prepaid expenses and other current assets | 4,862 | 4,028 |
Total current assets | 141,258 | 129,627 |
Property and equipment, net | 12,494 | 9,856 |
Restricted cash | 1,764 | 1,764 |
Operating lease assets | 6,868 | 8,042 |
Total assets | 162,384 | 149,289 |
Current liabilities: | ||
Accounts payable | 3,984 | 5,123 |
Accrued expenses and other current liabilities | 28,887 | 24,097 |
Deferred revenue | 317 | 576 |
Operating lease liabilities | 1,878 | 1,599 |
Total current liabilities | 35,066 | 31,395 |
Other liabilities: | ||
Operating lease liabilities, net of current portion | 7,251 | 8,678 |
Derivative liabilities | 24,022 | 6,351 |
Deferred revenue, net of current portion | 14,197 | 13,387 |
Notes payable, net | 65,124 | 25,257 |
Other non-current liabilities | 106 | 93 |
Convertible Notes, net | 8,765 | 28,749 |
Total liabilities | 154,531 | 113,910 |
Commitments and contingencies (Note 14) | ||
Stockholders' equity: | ||
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at September 30, 2023 and December 31, 2022, respectively | ||
Common stock, $0.0001 par value; 200,000,000 shares authorized and 79,412,114 and 77,201,819 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively | 8 | 8 |
Additional paid-in capital | 676,203 | 652,213 |
Accumulated deficit | (668,358) | (616,842) |
Total stockholders' equity | 7,853 | 35,379 |
Total liabilities and stockholders' equity | $ 162,384 | $ 149,289 |
CEO | Mr. Antony Mattessich |
---|---|
WEBSITE | www.ocutx.com |
EMPLOYEES | 274 |